Oscar Health (NYSE:OSCR – Get Rating) had its price target cut by equities researchers at Morgan Stanley from $18.00 to $12.00 in a report issued on Thursday, Stock Target Advisor reports. The firm currently has an “overweight” rating on the stock. Morgan Stanley’s target price would indicate a potential upside of 138.57% from the stock’s previous close.
Other equities research analysts have also issued reports about the company. Zacks Investment Research raised Oscar Health from a “hold” rating to a “buy” rating and set a $5.50 price target for the company in a research note on Thursday, June 2nd. Bank of America lowered Oscar Health from a “buy” rating to a “neutral” rating and decreased their target price for the company from $12.00 to $6.00 in a research report on Thursday, May 26th. One analyst has rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $9.14.
Shares of NYSE:OSCR traded down $0.19 during trading on Thursday, hitting $5.03. The company had a trading volume of 14,370 shares, compared to its average volume of 2,544,939. The stock has a market cap of $1.06 billion, a price-to-earnings ratio of -1.88 and a beta of 0.78. Oscar Health has a one year low of $4.48 and a one year high of $29.59. The company has a fifty day simple moving average of $7.05 and a two-hundred day simple moving average of $7.61. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.20 and a quick ratio of 1.20.
Oscar Health (NYSE:OSCR – Get Rating) last issued its quarterly earnings results on Tuesday, May 10th. The company reported ($0.36) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.40) by $0.04. Oscar Health had a negative return on equity of 37.23% and a negative net margin of 22.93%. During the same quarter last year, the company posted ($0.98) earnings per share. On average, equities research analysts anticipate that Oscar Health will post -2.53 earnings per share for the current year.
In other Oscar Health news, CFO Richard Scott Blackley sold 19,546 shares of the business’s stock in a transaction dated Monday, June 6th. The stock was sold at an average price of $5.01, for a total transaction of $97,925.46. Following the sale, the chief financial officer now owns 264,307 shares in the company, valued at approximately $1,324,178.07. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Alessandrea C. Quane sold 11,300 shares of the business’s stock in a transaction dated Monday, June 6th. The shares were sold at an average price of $5.01, for a total value of $56,613.00. Following the sale, the executive vice president now owns 131,018 shares in the company, valued at approximately $656,400.18. The disclosure for this sale can be found here.
Hedge funds have recently modified their holdings of the company. Psagot Value Holdings Ltd. Israel lifted its holdings in shares of Oscar Health by 210.3% in the 4th quarter. Psagot Value Holdings Ltd. Israel now owns 2,371 shares of the company’s stock valued at $4,518,000 after buying an additional 1,607 shares during the period. Advisor Group Holdings Inc. lifted its holdings in shares of Oscar Health by 116.8% in the 4th quarter. Advisor Group Holdings Inc. now owns 3,924 shares of the company’s stock valued at $30,000 after buying an additional 2,114 shares during the period. Aquire Wealth Advisors LLC acquired a new position in shares of Oscar Health in the 4th quarter valued at about $34,000. Royal Bank of Canada lifted its holdings in shares of Oscar Health by 3,837.2% in the 2nd quarter. Royal Bank of Canada now owns 5,709 shares of the company’s stock valued at $123,000 after buying an additional 5,564 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank acquired a new position in shares of Oscar Health in the 4th quarter valued at about $47,000. 98.65% of the stock is owned by institutional investors and hedge funds.
About Oscar Health (Get Rating)
Oscar Health, Inc provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients.
Recommended Stories
Receive News & Ratings for Oscar Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Oscar Health and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
